Real-World Effectiveness of Pharmaceutical Smoking Cessation Aids: Time-Varying Effects

Nicotine and Tobacco Research

Volumn 22, Issue 4, 2021, Pages 506-511

  Chaiton, Michael ^a   Diemert, Lori M ^a   Bondy, Susan J ^a   Cohen, Joanna E ^a,b   Fung, Michael D ^a   Zhang, Bo R ^a   Ferrence, Roberta G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE GUM; NICOTINE PATCH; VARENICLINE; BENZAZEPINE DERIVATIVE; NICOTINIC AGENT; PHARMACEUTICAL VEHICLES AND ADDITIVES;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONFOUNDING VARIABLE; CONTROLLED STUDY; DRUG DEPENDENCE TREATMENT; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ONTARIO; POPULATION RESEARCH; QUESTIONNAIRE; REAL WORLD EFFECTIVENESS; RELAPSE; SMOKING; SMOKING CESSATION; TELEMEDICINE; TOBACCO DEPENDENCE; ADOLESCENT; EPIDEMIOLOGY; HEALTH BEHAVIOR; PROCEDURES; PSYCHOLOGY; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BENZAZEPINES; BUPROPION; FEMALE; HEALTH BEHAVIOR; HUMANS; MALE; MIDDLE AGED; NICOTINIC AGONISTS; ONTARIO; PHARMACEUTIC AIDS; SMOKERS; SMOKING; SMOKING CESSATION; TIME FACTORS; TOBACCO USE CESSATION DEVICES; TOBACCO USE DISORDER; VARENICLINE; YOUNG ADULT;

EID: 85068589927     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/nty194     Document Type: Article

References (24)

1. Hyland A, Borland R, Li Q, et al. Individual-level predictors of cessation behaviours among participants in the International Tobacco Control (ITC) Four Country Survey. Tob Control. 2006;15(suppl 3):iii83-iii94.
2. Borland R, Partos TR, Yong HH, Cummings KM, Hyland A. How much unsuccessful quitting activity is going on among adult smokers? Data from the International Tobacco Control Four Country cohort survey. Addiction. 2012;107(3):673-682.
3. Hughes JR, Solomon LJ, Naud S, Fingar JR, Helzer JE, Callas PW. Natural history of attempts to stop smoking. Nicotine Tob Res. 2014;16(9):1190-1198.
4. Hughes JR, Peters EN, Naud S. Effectiveness of over-the-counter nicotine replacement therapy: a qualitative review of nonrandomized trials. Nicotine Tob Res. 2011;13(7):512-522.
5. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2017; (3). Art. No.: CD001292. doi:10.1002/14651858.CD001292.pub3
6. West R, Zhou X. Is nicotine replacement therapy for smoking cessation effective in the "real world"? Findings from a prospective multinational cohort study. Thorax. 2007;62(11):998-1002.
7. Miller N, Frieden TR, Liu SY, et al. Effectiveness of a large-scale distribution programme of free nicotine patches: a prospective evaluation. Lancet. 2005;365(9474):1849-1854.
8. Kasza KA, Hyland AJ, Borland R, et al. Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction. 2013;108(1):193-202.
9. Zhou X, Nonnemaker J, Sherrill B, Gilsenan AW, Coste F, West R. Attempts to quit smoking and relapse: factors associated with success or failure from the ATTEMPT cohort study. Addict Behav. 2009;34(4):365-373.
10. Shiffman S, Brockwell SE, Pillitteri JL, Gitchell JG. Use of smoking- cessation treatments in the United States. Am J Prev Med. 2008;34(2):102-111.
11. Yang J, Hammond D, Driezen P, et al. The use of cessation assistance among smokers from China: findings from the ITC China survey. BMC Public Health. 2011;11:75.
12. Alpert HR, Connolly GN, Biener L. A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation. Tob Control. 2013;22(1):32-37.
13. Pierce JP, Gilpin EA. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA. 2002;288(10):1260-1264.
14. Kotz D, Brown J, West R. 'Real-world' effectiveness of smoking cessation treatments: a population study. Addiction. 2014;109(3):491-499.
15. Kotz D, Brown J, West R. Prospective cohort study of the effectiveness of varenicline versus nicotine replacement therapy for smoking cessation in the "real world". BMC Public Health. 2014;14:1163.
16. Heckman BW, Cummings KM, Kasza KA, et al. Effectiveness of switching smoking-cessation medications following relapse. Am J Prev Med. 2017;53(2):e63-e70.
17. Siahpush M, Shaikh RA, McCarthy M, Sikora Kessler A, Tibbits M, Singh GK. Association between duration of use of pharmacotherapy and smoking cessation: findings from a national survey. BMJ Open. 2015;5(1):e006229.
18. Zhang B, Cohen JE, Bondy SJ, Selby P. Duration of nicotine replacement therapy use and smoking cessation: a population-based longitudinal study. Am J Epidemiol. 2015;181(7):513-520.
19. Yong HH, Borland R, Cummings KM, Partos T. Do predictors of smoking relapse change as a function of duration of abstinence? Findings from the United States, Canada, United Kingdom and Australia. Addiction. 2018;113(7):1295-1304.
20. Diemert LM, Bondy SJ, Victor JC, et al. Efficient screening of current smoking status in recruitment of smokers for population-based research. Nicotine Tob Res. 2008;10(11):1663-1667.
21. Diemert L, Victor JC, Chaiton M, et al. Ontario Tobacco Survey Technical Report 1: Baseline Data. Toronto, ON: Ontario Tobacco Research Unit; 2010. Available from http://www.otru.org/pdf/ots/OTS- Technical-Report.pdf
22. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989;84(7):791-799.
23. Royston P, Parmar MK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med. 2002;21(15):2175-2197.
24. Tønnesen P, Paoletti P, Gustavsson G, et al. Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European anti-smoking evaluation. European Respiratory Society. Eur Respir J. 1999;13(2):238-246.